Search

Your search keyword '"Jyrki Lötjönen"' showing total 261 results

Search Constraints

Start Over You searched for: Author "Jyrki Lötjönen" Remove constraint Author: "Jyrki Lötjönen"
261 results on '"Jyrki Lötjönen"'

Search Results

1. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly

2. Use of a digital tool to support the diagnostic process in memory clinics–a usability study

3. Subjective cognitive complaints are related to depressive symptoms but not objective impairment in covert cerebral small vessel disease

4. COMBINED ASSOCIATIONS OF COGNITIVE AND MOTOR IMPAIRMENTS WITH FUNCTIONAL OUTCOME IN COVERT CEREBRAL SMALL VESSEL DISEASE

5. NEUROFILAMENT LIGHT LEVEL CORRELATES WITH BRAIN ATROPHY AND COGNITIVE AND MOTOR PERFORMANCE IN SUBJECTS WITH CEREBRAL WHITE MATTER HYPERINTENSITIES

7. Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET.

8. Precision medicine in neurodegeneration: the IHI-PROMINENT project

9. Subjective vs informant-reported cognitive complaints have differential clinical significance in covert cerebral small vessel disease

10. Neurofilament light level correlates with brain atrophy, and cognitive and motor performance

11. Grey matter atrophy in patients with benign multiple sclerosis

12. Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)

13. Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study

14. Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study

15. Effects of White Matter Hyperintensities on Verbal Fluency in Healthy Older Adults and MCI/AD

16. Identifying causative mechanisms linking early-life stress to psycho-cardio-metabolic multi-morbidity: The EarlyCause project.

17. Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis

18. Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline

19. Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort

20. Brain volumes in relation to loneliness and social competence in preadolescents born very preterm

21. Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy.

22. cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders

23. Evaluating 2-[18F]FDG-PET in differential diagnosis of dementia using a data-driven decision model

24. Predicting Global Cognitive Decline in the General Population Using the Disease State Index

25. Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease

26. Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis

27. Computer‐assisted prediction of clinical progression in the earliest stages of AD

28. Evaluating combinations of diagnostic tests to discriminate different dementia types

29. Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting

30. The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia

31. Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis

32. Detecting frontotemporal dementia syndromes using MRI biomarkers

33. Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease

34. Differential diagnosis of neurodegenerative diseases using structural MRI data

35. Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier

36. Regional brain morphometry in patients with traumatic brain injury based on acute- and chronic-phase magnetic resonance imaging.

37. Quantification of dynamic morphological drug responses in 3D organotypic cell cultures by automated image analysis.

38. Predicting AD conversion: comparison between prodromal AD guidelines and computer assisted PredictAD tool.

39. Improved classification of Alzheimer's disease data via removal of nuisance variability.

40. Structural MRI in frontotemporal dementia: comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometry.

41. Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease.

42. Serum lipidomics meets cardiac magnetic resonance imaging: profiling of subjects at risk of dilated cardiomyopathy.

43. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.

49. Synergistic associations of cognitive and motor impairments with functional outcome in covert cerebral small vessel disease

Catalog

Books, media, physical & digital resources